Cubist Systematic Strategies’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Cubist Systematic Strategies’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-63,702	Closed	-$524K	–	4989
2022 Q3	$524K	Buy	+63,702	New	+$489K	﹤0.01%	3130
2021 Q4	–	Sell	-33,548	Closed	-$207K	–	3774
2021 Q3	$207K	Buy	+33,548	New	+$201K	﹤0.01%	2569
2018 Q4	–	Sell	-1,290	Closed	-$43K	–	2396
2018 Q3	$43K	Sell	1,290 -319	-20%	-$8.2K	﹤0.01%	1731
2018 Q2	$36K	Buy	1,609 +238	+17%	+$5.64K	﹤0.01%	1673
2018 Q1	$40K	Buy	1,371 +1,291	+1,614%	+$37.8K	﹤0.01%	1719
2017 Q4	$2K	Sell	80 -1,053	-93%	-$32.7K	﹤0.01%	1869
2017 Q3	$41K	Sell	1,133 -1,167	-51%	-$36.1K	﹤0.01%	1743
2017 Q2	$51K	Buy	+2,300	New	+$18.1K	﹤0.01%	1546

Other funds holding AVEO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Cubist Systematic Strategies's AVEO Position: Q4 2022 in Review

Cubist Systematic Strategies sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q4 2022, closing a stake of 63,702 shares — an estimated $524K sold.

Cubist Systematic Strategies first reported a position in AVEO in Q2 2017 and held it in 8 quarters. The position peaked at $524K in Q3 2022. 110 funds tracked by Wall St. Rank hold AVEO as of Q4 2022.

Cubist Systematic Strategies reported no remaining AVEO Pharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
Cubist Systematic Strategies sold 63,702 AVEO Pharmaceuticals, Inc. shares in Q4 2022, an estimated $524K.
Cubist Systematic Strategies first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2017 and held it in 8 quarters.
Cubist Systematic Strategies's AVEO Pharmaceuticals, Inc. position peaked at $524K in Q3 2022.
110 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q4 2022.

Based on Cubist Systematic Strategies's 13F filing for Q4 2022, filed 14 Feb 2023.